Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 21 Oct 2025

Evaluating the effectiveness of integrated care in targeted therapy for patients with chronic lymphocytic leukemia

in Hematologic Malignancies

Xin Liu
Wumin Chen
Meiying Wang
Yan Gao
Xueqin Kou
Xianna Pan
Lijuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1685510

179 views

Original Research

Published on 20 Oct 2025

Unveiling hypoxic regulatory networks by bioinformatics: mechanisms of hypoxia-related hub genes driving rituximab resistance and poor prognosis in DLBCL

in Hematologic Malignancies

Jiayi Yao
Juan Huang
Yuanfei Mao
Zizhen Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592441

444 views

Case Report

Published on 20 Oct 2025

Isolated central nervous system relapse in acute myeloid leukemia: a case report and review of therapeutic challenges

in Hematologic Malignancies

Colin Burns
Ian Muir
Jennifer Foster
Anthony Emanuel
Mark Kochenderfer

Frontiers in Oncology

doi 10.3389/fonc.2025.1667681

426 views

Case Report

Published on 17 Oct 2025

Hereditary spherocytosis concomitant with JAK2V617F-positive primary myelofibrosis: a case report

in Hematologic Malignancies

Chi-E Qiu
Lei Lei
Guosong Jiang
Xiuqun Huang
Yadan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1665179

376 views

Case Report

Published on 17 Oct 2025

Acute obinutuzumab-induced thrombocytopenia in follicular lymphoma: case report and literature review

in Hematologic Malignancies

Jieyi Zhou
Miaomiao Chen
Yi Zhang
Ce Xu
Rong Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1643313

450 views

Systematic Review

Accepted on 16 Oct 2025

Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials

in Hematologic Malignancies

Bin Hu
Jun Wang
Dan Fang
Ling Jiang
Tianqi Li
Jinxia Cao

Frontiers in Oncology

doi 10.3389/fonc.2025.1619115

123 views

Original Research

Accepted on 16 Oct 2025

Application of Radiomics model Based on FDG-PET/CT for the Assessment of Therapeutic Effect in Patients with Newly-diagnosed Multiple Myeloma

in Hematologic Malignancies

Fukai Li
Fei Li
Xiaodan Xu
Qingyang Yu
Guangwen Duan
Jiayang Yan
Baiyang Jiang
Hongbiao Sun
Shaochun Xu
Xiang Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1647730

104 views

Original Research

Accepted on 16 Oct 2025

Relapsed or Refractory Central Nervous System Lymphoma Successfully Treated by Glofitamab Combined with Lenalidomide

in Hematologic Malignancies

Yin-yin Peng
Xiao-qiong Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1685271

112 views

Systematic Review

Accepted on 16 Oct 2025

Safety of totally implantable venous access devices and peripherally inserted central catheters in hematological malignancies patients: A meta-analysis

in Hematologic Malignancies

Meier Gu
Xiaguang Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1679363

Original Research

Published on 16 Oct 2025

Targeting the N-cadherin/β-catenin axis with MSAB reverses malignant phenotypes in blast crisis of CML

in Hematologic Malignancies

Yingying Zhou
Songqin Jian
Lijun Lu
Xiaofang Li
Ruyi Qiu

Frontiers in Oncology

doi 10.3389/fonc.2025.1657508

345 views

Original Research

Published on 16 Oct 2025

B7-H7 knockdown suppresses the proliferation, metastasis, and drug resistance of B-cell non-Hodgkin lymphoma cells by inhibiting the PI3K/Akt pathway

in Hematologic Malignancies

Aili Zhai
Qing Zou
Jiawei Yin
Shixin Ge
Xingfang Xiong
Tao Yan
Xiaoli Xie
Lijuan Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1665309

497 views

Systematic Review

Accepted on 15 Oct 2025

Efficacy and Safety of Inotuzumab Ozogamicin and Its Combination Therapies in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis

in Hematologic Malignancies

Changtao Lao
Jiange Wen
Yuezhen Wen

Frontiers in Oncology

doi 10.3389/fonc.2025.1613777

128 views

Systematic Review

Published on 15 Oct 2025

Comparing therapeutic effects of hematopoietic stem cell transplantation, tyrosine kinase inhibitors and chemotherapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a systematic review and meta-analysis

in Hematologic Malignancies

Xiaohui Gao
Hui Zeng
Fei Sun
Xiaoyan Zhao
Haibing Wu
Minchao Yan
Yuan Li
Qinyan Fu
Gang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1627825

520 views

Original Research

Accepted on 14 Oct 2025

Prognostic Value of Lymphocyte Subsets in Diffuse Large B cell Lymphoma

in Hematologic Malignancies

Lihua Qiu
Lijing Xing
Meng Zhao
Biwen Sun
Xinpei Zhou
Min Li
Guoguang Ying
Huilai Zhang
Chen Tian

Frontiers in Oncology

doi 10.3389/fonc.2025.1671062

261 views

Original Research

Accepted on 14 Oct 2025

Efficacy and safety of hetrombopag in the treatment of chemotherapy-related thrombocytopenia in solid tumors: a retrospective study

in Hematologic Malignancies

Yuan Yuan
Qiang Tong
Jia-Hui Liu
Ye Kang

Frontiers in Oncology

doi 10.3389/fonc.2025.1670029

Editorial

Accepted on 13 Oct 2025

Editorial: Immunotherapy and Cell Therapy for Patients with Relapsed and Refractory Acute Myeloid Leukemia

in Hematologic Malignancies

Jing-Yi Huang
Shi-Yao Song
Xiaotian Zhang
Chunliang Li
Yan-Lai Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1691911

123 views